Literature DB >> 12950177

Human neutrophils as a source of nociceptin: a novel link between pain and inflammation.

Marie-Elaine Fiset1, Caroline Gilbert, Patrice E Poubelle, Marc Pouliot.   

Abstract

Nociceptin is a neuropeptide sharing sequence homology with classical opioid peptides but with a distinct pharmacological profile. Through activation of its receptor, NociR, nociceptin has been linked with several physiological functions in the central nervous system including memory, locomotion, and processing of pain signals. Recently, peripheral blood neutrophils (PMNs) were demonstrated to express a functional NociR, a result suggesting that additional functions of the neuropeptide remain to be elucidated. The present study investigated the possibility that PMNs may be a source of nociceptin and whether the neuropeptide elicits PMN early responses. We observed the presence of nociceptin in the synovial fluids from arthritic patients, an inflammatory milieu typically containing high numbers of PMNs. In addition, freshly isolated PMNs were found to express and secrete nociceptin following degranulation, identifying these inflammatory cells as a novel source of the neuropeptide. Incubation of PMNs with nociceptin elicited a specific pattern of cellular protein phosphorylation on tyrosine residues in a rapid and transient fashion. Moreover, nociceptin prevented intracellular accumulation of cAMP in fMLP-stimulated PMNs, an effect mimicked by the specific NociR synthetic agonist, Ro 64-6198. Taken together, these results show that nociceptin/NociR is present and functional in human neutrophils, and the results identify a novel dialogue pathway between neural and immune tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950177      PMCID: PMC2881299          DOI: 10.1021/bi0300635

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

Review 1.  The neutrophil as a cellular source of chemokines.

Authors:  P Scapini; J A Lapinet-Vera; S Gasperini; F Calzetti; F Bazzoni; M A Cassatella
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

2.  Neither nociceptin nor its receptor are present in human synovial fluid or tissue.

Authors:  N Kumar; D Smart; S Mason; A T McKnight; D J Rowbotham; D G Lambert
Journal:  Br J Anaesth       Date:  1999-09       Impact factor: 9.166

Review 3.  Opiate modulating properties of nociceptin/orphanin FQ.

Authors:  L M Harrison; D K Grandy
Journal:  Peptides       Date:  2000-01       Impact factor: 3.750

4.  Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances.

Authors:  S W Hwang; H Cho; J Kwak; S Y Lee; C J Kang; J Jung; S Cho; K H Min; Y G Suh; D Kim; U Oh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Adenosine receptor occupancy suppresses chemoattractant-induced phospholipase D activity by diminishing membrane recruitment of small GTPases.

Authors:  N Thibault; D Harbour; P Borgeat; P H Naccache; S G Bourgoin
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

Review 6.  Transmitters involved in antinociception in the spinal cord.

Authors:  S Fürst
Journal:  Brain Res Bull       Date:  1999-01-15       Impact factor: 4.077

Review 7.  Opioid receptor signalling mechanisms.

Authors:  M Connor; M D Christie
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-07       Impact factor: 2.557

8.  Measurement of prostaglandin E2 and leukotriene B4 in the gingival crevicular fluid.

Authors:  C C Tsai; Y C Hong; C C Chen; Y M Wu
Journal:  J Dent       Date:  1998-03       Impact factor: 4.379

9.  Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6.

Authors:  P Rameshwar; D Ganea; P Gascón
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

10.  Interleukin-6 secretion from human astrocytoma cells induced by substance P.

Authors:  B D Gitter; D Regoli; J J Howbert; A L Glasebrook; D C Waters
Journal:  J Neuroimmunol       Date:  1994-04       Impact factor: 3.478

View more
  23 in total

1.  [Expression und function of the ORL-1 receptor on human leukocytes].

Authors:  C Krüger; L Köthe; A Struppert; C Pietruck; A Simm; S Grond
Journal:  Schmerz       Date:  2006-11       Impact factor: 1.107

2.  Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.

Authors:  Aldo Spadaro; Antonino Ajello; Carmelo Luigiano; Carmela Morace; Maria Letizia Resta; Grazia Berlinghieri; Salvatore Campo; Claudio Scisca; Angela Alibrandi; Graziella D'Arrigo; Nunziata Alessi; Oscar Ferrau; Maria Antonietta Freni
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

3.  Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees.

Authors:  Chunfen Zhang; Jason J McDougall
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

4.  Nociceptin/orphanin FQ receptor-driven heterologous desensitization of the major HIV-1 co-receptor CXCR4.

Authors:  David E Kaminsky; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2011-06-09       Impact factor: 4.147

5.  Nociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro.

Authors:  Benito Anton; Phillipe Leff; Joseph J Meissler; Juan C Calva; Rodolfo Acevedo; Alberto Salazar; Maura Matus; Anabel Flores; Martin Martinez; Martin W Adler; John P Gaughan; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-02       Impact factor: 4.147

6.  Orphanin FQ/nociceptin activates nuclear factor kappa B.

Authors:  Courtney L Donica; Vanessa I Ramirez; Hibah O Awwad; Nurulain T Zaveri; Lawrence Toll; Kelly M Standifer
Journal:  J Neuroimmune Pharmacol       Date:  2011-05-06       Impact factor: 4.147

Review 7.  Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression.

Authors:  M J Finley; C M Happel; D E Kaminsky; T J Rogers
Journal:  Cell Immunol       Date:  2008-02-14       Impact factor: 4.868

8.  The nociceptin/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis.

Authors:  Dickson Carvalho; Fabricia Petronilho; Francieli Vuolo; Roberta Albino Machado; Larissa Constantino; Remo Guerrini; Girolamo Calo; Elaine Cristina Gavioli; Emílio Luiz Streck; Felipe Dal-Pizzol
Journal:  Intensive Care Med       Date:  2008-10-10       Impact factor: 17.440

Review 9.  Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Authors:  Courtney L Donica; Hibah O Awwad; Deepak R Thakker; Kelly M Standifer
Journal:  Mol Pharmacol       Date:  2013-02-08       Impact factor: 4.436

10.  Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes.

Authors:  David E Kaminsky; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2007-09-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.